4D Medicine raised £3.4M in a Series A investment led by Oshen Holdings and backed by DSW Ventures, SFC Capital, Boundary Capital, and private investors.

4D Medicine, a UK-based startup, has raised £3.4 million in Series A investment. The round was led by Oshen Holdings and backed by DSW Ventures, SFC Capital, Boundary Capital, and private investors. The company, founded in 2020, has developed a resorbable biomaterial, 4Degra, to develop implants for patients recovering from surgery or injuries. The funding will enable the company to complete pre-clinical testing of its first product range and seek FDA clearance for entry into the US market.